Cnat stock news today

Conatus... (CNAT) Stock Quote | Price Chart | Volume Chart View a financial market summary for CNAT including stock price quote, trading volume, volatility, options volume, statistics, and other important company data related to CNAT (Conatus Pharmaceuticals Inc.) stock. All · Charts · Trade Ideas · Sentiment · News · Stats. Charts for Today's Stock Price and Implied Volatility in Conatus NASDAQ | CNAT: Stock News, Ratings & Analysis for Conatus ...

CNAT Stock | CONATUS PHARMACEUTICALS Stock Price Today ... CNAT: Get the latest Conatus Pharmaceuticals stock price and detailed information including CNAT news, historical charts and realtime prices. CNAT | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CONATUS PHARMACEUTICALS INC (CNAT), including profile, stock chart, recent news and …

CNAT Price Target and Analyst Ratings (Conatus ...

CNAT -- Is Its Stock Price A Worthy Investment? Learn More. CNAT Stock Summary. CNAT has a market capitalization of $13,832,093 -- more than approximately just 5.84% of US stocks. For CNAT, its debt to operating expenses ratio is greater than that reported by merely 8.5% of US equities we're observing. CNAT Stock | CONATUS PHARMACEUTICALS Stock Price Today ... CNAT: Get the latest Conatus Pharmaceuticals stock price and detailed information including CNAT news, historical charts and realtime prices. CNAT | Stock Snapshot - Fidelity Apr 03, 2020 · Stock quote and company snapshot for CONATUS PHARMACEUTICALS INC (CNAT), including profile, stock chart, recent news and … CNAT Stock Quote - Conatus Pharmaceuticals, Inc. Stock ...

Drug Stock Poised to Lose Half its Value After Dismal Data

CNET news editors and reporters provide top technology news, with investigative reporting and in-depth coverage of tech issues and events.

CNAT | Conatus Pharmaceuticals Inc. Advanced Charts ...

Technology News - CNET News - CNET CNET news editors and reporters provide top technology news, with investigative reporting and in-depth coverage of tech issues and events. Conatus Pharmaceuticals (CNAT) Stock Crashes After Trial ...

CNAT Stock Price and Chart — NASDAQ:CNAT — TradingView

Conatus Pharmaceuticals Inc. (CNAT) stock fell over 50% today amid disappointing results for the company’s 2b ENCORE-PH clinical trial in NASH cirrhosis.

Current stock quote for Conatus Pharmaceuticals Inc. ( CNAT ) including financial statements, level 2 data, and the latest Biotechnology news, research, and